Medical Strategy Lead, Oncology
Pubblicato il 17-10-2026 - Iqvia in Pordenone
Job Overview Job Overview The Medical Director for the Hematology-Oncology Center of Excellence provides strategic medical and scientific subject matter input to IQVIA in this therapeutic area informed by their training, experience and expertise. The activity of the medical director includes but is not necessarily limited to early engagement with potential customers, proposal development in response to RFPs, participation in client proposal bid‑defense meetings, support at scientific conferences, participation in thought leadership activities, contribution as needed to the formulation of clinical development plans, providing medical director and subject matter expertise as a consultant throughout the research and development lifecycle and the duration of clinical trials, and engagement with colleagues as an internal reference SME for hematology‑oncology. Greater independence is expected to be demonstrated over time for medical director activities under the supervision of the therapeutic area head and leadership team.
Essential Functions Work independently under the supervision (direct or indirect) of the Hematology‑Oncology Center of Excellence Head and COE Leadership team. * Provide scientific and clinical advice to internal stakeholders developing proposals, including but not limited to: protocol design/ clinical development plan, insights on mechanism of action of the investigational product, mining data to address important clinical questions relevant to the study, reviewing protocol for scientific/regulatory soundness and feasibility, identification of target site and principle investigator profiles, anticipated patient recruitment, standards of care and competitive landscape. * Maintain awareness of latest literature to keep abreast of scientific progress in hematology and oncology. * Participate as needed in the preparation for and conduct of client meetings, such as early engagement, proposal discussion and bid defense meetings, post‑award transition and gov